Q2i Partners with MaineHealth to Implement SIMS Technology for Contingency Management in Stimulant Use Treatment
Boston, MA. 15th April 2025 MaineHealth has adopted contingency management (CM) as an evidence-based strategy for treating stimulant use disorder. Contingency Management Innovations (CMI), the CM division of Q2i, offers advanced technology to address stimulant use...
Q2i Reports Significant Milestone in California’s Statewide Contingency Management Program for Stimulant Use Treatment
Boston, MA – 11 March 2025 Q2i today announced its pivotal role in the successful rollout of the Recovery Incentives Program: California’s Contingency Management benefit for stimulant use disorder treatment. Powered by Q2i’s advanced State Incentive Management System...